Tetiana Yakovenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tetiana Yakovenko has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Tetiana Marchyshak
Institute of Molecular Biology and Genetics National Academy of Sciences of Ukraine
3 shared publications - Zenoviy Tkachuk
Institute of Molecular Biology and Genetics, NAS of Ukraine
3 shared publications - Igor Shmarakov
Department of Biochemistry and Biotechnology, Chernivtsi National University, Chernivtsi, Ukraine
1 shared publication - Larisa Semernikova
Institute of Molecular Biology and Genetics National Academy of Sciences of Ukraine
1 shared publication
Latest Publications
- Open Access
- 30 June 2020
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 3(24),p. 35-40
Effect of oligoribonucleotides with D-mannitol complexes on oxidative stress indicators against thioacetamide-induced liver fibrosis
The aim of the study. To determine the effect of oligoribonucleotides-D-mannitol complexes (ORN-D-M) on the indicators of oxidative destruction of biomolecules and the antioxidant system of cells in thioacetamide (TAA)-induced liver fibrosis. Materials and methods. Liver fibrosis was induced for 8 weeks by intraperitoneal administration of TAA (150 mg/kg body weight). ORN-D-M (200 mg/kg per os) was administered orally during intoxication. At the end of the experiment, the liver was excised and examined for the content of oxidative stress products and the activity of antioxidant enzymes. Data were analyzed using the ANOVA test followed by Tukey post hoc testing. Results. It is shown that the monotherapeutic treatment of ORN-D-M in TAA-induced liver fibrosis has a pronounced protective effect, which is manifested in the reduction of oxidative stress. ORN-D-M led to the attenuation of free radical damage of biopolymers, which was manifested in a decrease in the levels of peroxidation products of lipids and proteins with a simultaneous increase in the level of protein thiol groups and reduced glutathione. In addition, treatment with complexes increased the activity of the antioxidant defence system of cells. Conclusions. The obtained results indicate that ORN-D-M complexes have a potential hepatoprotective effect in TAA-induced liver fibrosis. The complexes are able to effectively reduce the indicators of oxidative damage of biomolecules with a simultaneous increase in the activity of enzymes of the antioxidant system in TAA-induced fibrosis
- 30 June 2020
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 3(24),p. 35-40
Open AccessEffect of oligoribonucleotides with D-mannitol complexes on oxidative stress indicators against thioacetamide-induced liver fibrosis
The aim of the study. To determine the effect of oligoribonucleotides-D-mannitol complexes (ORN-D-M) on the indicators of oxidative destruction of biomolecules and the antioxidant system of cells in thioacetamide (TAA)-induced liver fibrosis. Materials and methods. Liver fibrosis was induced for 8 weeks by intraperitoneal administration of TAA (150 mg/kg body weight). ORN-D-M (200 mg/kg per os) was administered orally during intoxication. At the end of the experiment, the liver was excised and examined for the content of oxidative stress products and the activity of antioxidant enzymes. Data were analyzed using the ANOVA test followed by Tukey post hoc testing. Results. It is shown that the monotherapeutic treatment of ORN-D-M in TAA-induced liver fibrosis has a pronounced protective effect, which is manifested in the reduction of oxidative stress. ORN-D-M led to the attenuation of free radical damage of biopolymers, which was manifested in a decrease in the levels of peroxidation products of lipids and proteins with a simultaneous increase in the level of protein thiol groups and reduced glutathione. In addition, treatment with complexes increased the activity of the antioxidant defence system of cells. Conclusions. The obtained results indicate that ORN-D-M complexes have a potential hepatoprotective effect in TAA-induced liver fibrosis. The complexes are able to effectively reduce the indicators of oxidative damage of biomolecules with a simultaneous increase in the activity of enzymes of the antioxidant system in TAA-induced fibrosis
- Open Access
- 3 November 2018
- Published by MDPI AG
Hepatoprotective and antioxidant effects of oligoribonucleotides-D-mannitol complexes against thioacetamide-induced liver fibrosis
Aim: Hepatic fibrosis is a common consequence of chronic liver injury caused by a variety of etiological factors. It is associated with inflammation, oxidative stress, necrosis and ends with cirrhosis, liver cancer, or liver failure. Oligoribonucleotides-D-mannitol complexes (ORNs-D-M) display a vast spectrum of biological effects, including cellular metabolism stimulation with activation of endogenous synthesis of regulatory proteins, stimulation of reparation processes. Therefore, the aim of this study was to investigate the protective effect of the ORNs-D-M on liver fibrosis. Materials and methods: Mice received thioacetamide (TAA) (200 mg/kg, intraperitoneal) thrice weekly, for 8 successive weeks to induce liver fibrosis. The ОRNs-D-M (200 mg/kg, per os) was administered orally during TAA intoxication. Body weights and mortality mice were assessed during the experiment. At the end of the experiment, oxidative stress, inflammatory and profibrogenic markers were evaluated. Results: The results of the research showed that treatment with the ORNs-D-M attenuated TAA-induced liver fibrosis in mice. The ORNs-D-M prevented TAA oxidative stress. The ORNs-D-M decreased TBA-reactive substances, carbonyl derivatives levels and myeloperoxidase activity by 60.6, 35 and 52% respectively in comparison to control thioacetamide in the liver cells. In addition, these complexes increased protein and non-protein thiol groups levels, and glutathione-S-transferase and glutathione peroxidase activities compared to the TAA-treated mice. During TAA-induced liver fibrosis, it was investigated that the ORNs-D-M reduced the expression mRNA level of pro-inflammatory (IL-6, TNF-α) genes by 40 and 56 % respectively, compared to the mice with TAA. Furthermore, the ORNs-D-M suppressed the HSCs/myofibroblasts activation by reduced expression of markers α-SMA, COL-1, and TGF-β1 in the liver. Conclusion: The ORNs-D-M could ameliorate the effects of TAA-induced liver fibrosis in mice by inhibiting oxidative stress, expressions of pro-inflammatory cytokines and profibrotic markers.
- 3 November 2018
- Published by MDPI AG
Open AccessHepatoprotective and antioxidant effects of oligoribonucleotides-D-mannitol complexes against thioacetamide-induced liver fibrosis
Aim: Hepatic fibrosis is a common consequence of chronic liver injury caused by a variety of etiological factors. It is associated with inflammation, oxidative stress, necrosis and ends with cirrhosis, liver cancer, or liver failure. Oligoribonucleotides-D-mannitol complexes (ORNs-D-M) display a vast spectrum of biological effects, including cellular metabolism stimulation with activation of endogenous synthesis of regulatory proteins, stimulation of reparation processes. Therefore, the aim of this study was to investigate the protective effect of the ORNs-D-M on liver fibrosis. Materials and methods: Mice received thioacetamide (TAA) (200 mg/kg, intraperitoneal) thrice weekly, for 8 successive weeks to induce liver fibrosis. The ОRNs-D-M (200 mg/kg, per os) was administered orally during TAA intoxication. Body weights and mortality mice were assessed during the experiment. At the end of the experiment, oxidative stress, inflammatory and profibrogenic markers were evaluated. Results: The results of the research showed that treatment with the ORNs-D-M attenuated TAA-induced liver fibrosis in mice. The ORNs-D-M prevented TAA oxidative stress. The ORNs-D-M decreased TBA-reactive substances, carbonyl derivatives levels and myeloperoxidase activity by 60.6, 35 and 52% respectively in comparison to control thioacetamide in the liver cells. In addition, these complexes increased protein and non-protein thiol groups levels, and glutathione-S-transferase and glutathione peroxidase activities compared to the TAA-treated mice. During TAA-induced liver fibrosis, it was investigated that the ORNs-D-M reduced the expression mRNA level of pro-inflammatory (IL-6, TNF-α) genes by 40 and 56 % respectively, compared to the mice with TAA. Furthermore, the ORNs-D-M suppressed the HSCs/myofibroblasts activation by reduced expression of markers α-SMA, COL-1, and TGF-β1 in the liver. Conclusion: The ORNs-D-M could ameliorate the effects of TAA-induced liver fibrosis in mice by inhibiting oxidative stress, expressions of pro-inflammatory cytokines and profibrotic markers.
- Open Access
- 6 August 2018
- Published by MDPI AG in Pharmaceuticals
- Vol. 11 (3) , 77
The Potential Protective Effect of Oligoribonucleotides-d-Mannitol Complexes against Thioacetamide-Induced Hepatotoxicity in Mice
This study investigated the potential hepatoprotective effect of oligoribonucleotides-d-mannitol complexes (ORNs-d-M) against thioacetamide (TAA)-induced hepatotoxicity in mice. The hepatoprotective activity of ORNs-d-M was evaluated in thioacetamide (TAA)-treated C57BL/6J. Results indicate that treatment with ORNs-d-M displayed a protective effect at the TAA-induced liver injury. Treatment with ORNs-d-M, starting at 0 h after the administration of TAA, decreased TAA-elevated serum alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (GGT). Activities of glutathione S-transferase (GST) and glutathione peroxidase (GPx), and levels of glutathione (GSH), were enhanced with ORNs-d-M administration, while the hepatic oxidative biomarkers (TBA-reactive substances, protein carbonyl derivatives, protein-SH group) and myeloperoxidase (MPO) activity were reduced. Furthermore, genetic analysis has shown that the ORNs-d-M decreases the expression of mRNA pro-inflammatory cytokines, such as tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6), profibrogenic cytokine-transforming growth factor β1 (TGF-β1), as well as the principal protein of the extracellular matrix—collagen I. The present study demonstrates that ORNs-d-M exerts a protective effect against TAA-induced liver injury, which may be associated with its anti-inflammatory effects, inhibition of overexpression of mRNA cytokines, and direct effects on the metabolism of the toxin.
- 6 August 2018
- Published by MDPI AG in Pharmaceuticals
- Vol. 11 (3) , 77
Open AccessThe Potential Protective Effect of Oligoribonucleotides-d-Mannitol Complexes against Thioacetamide-Induced Hepatotoxicity in Mice
This study investigated the potential hepatoprotective effect of oligoribonucleotides-d-mannitol complexes (ORNs-d-M) against thioacetamide (TAA)-induced hepatotoxicity in mice. The hepatoprotective activity of ORNs-d-M was evaluated in thioacetamide (TAA)-treated C57BL/6J. Results indicate that treatment with ORNs-d-M displayed a protective effect at the TAA-induced liver injury. Treatment with ORNs-d-M, starting at 0 h after the administration of TAA, decreased TAA-elevated serum alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (GGT). Activities of glutathione S-transferase (GST) and glutathione peroxidase (GPx), and levels of glutathione (GSH), were enhanced with ORNs-d-M administration, while the hepatic oxidative biomarkers (TBA-reactive substances, protein carbonyl derivatives, protein-SH group) and myeloperoxidase (MPO) activity were reduced. Furthermore, genetic analysis has shown that the ORNs-d-M decreases the expression of mRNA pro-inflammatory cytokines, such as tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6), profibrogenic cytokine-transforming growth factor β1 (TGF-β1), as well as the principal protein of the extracellular matrix—collagen I. The present study demonstrates that ORNs-d-M exerts a protective effect against TAA-induced liver injury, which may be associated with its anti-inflammatory effects, inhibition of overexpression of mRNA cytokines, and direct effects on the metabolism of the toxin.